Endoscopy plays a key role in diagnosis, monitoring of disease activity, assessment of treatment response, dysplasia surveillance, postoperative evaluation, and interventional therapy for patients with inflammatory bowel disease (IBD). Clinical practice patterns in the endoscopic management of IBD vary. A panel of experts consisting of IBD specialists, endoscopists, and GI pathologists participated in virtual conferences and developed this modified Delphi-based consensus document to address endoscopic aspects of IBD management., Competing Interests: Disclosure The following authors disclosed financial relationships: B. Shen: Consultant for Janssen; education and research support to Columbia University from Janssen, Takeda, Abbvie, GIE Medical, and Boomerang. M. T. Abreu: Research support from the National Institutes of Health Research, Department of Defense, The Leona M. and Harry B. Helmsley Charitable Trust, and Crohn’s and Colitis Foundation; consultant and advisory board for AbbVie, Alimentiv, Arena Pharmaceuticals Inc, Bristol Myers Squibb, Celsius Therapeutics, Eli Lilly and Company, Gilead Sciences Inc, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Pfizer Pharmaceutical, Prime CME, Takeda Pharmaceuticals, and WebMD Global LLC; speaker for Amgen Inc, Janssen Pharmaceutica NV, Prometheus Biosciences, and UCB Biopharma SRL. E. R. Cohen: Advisory board and consultant for Pfizer, Takeda, and PRIME Education; speaker for Abbvie, Eli Lilly and Company, Janssen, and Takeda. F. A. Farraye: Consultant for Avalo Therapeutics, BMS, Braintree Labs, Fresenius Kabi, GI Reviewers, GSK, IBD Educational Group, Iterative Health, Janssen, Pharmacosmos, Pfizer, Sandoz Immunology, Viatris, DSMB and Eli Lilly and Company; research support to the Mayo Clinic from BMS, Creatics, Janssen, and Takeda. M. Fischer: Consultant and advisory board for Abbvie, Bristol Myers Squibb, Janssen Pharmaceuticals, Eli Lilly, Seres, Ferring, and DSMB for Rebiotix; teacher for Bristol Myers Squibb and Eli Lilly. S. Kapur: Advisory board for Pfizer; speaker for Abbvie, Jenssen, Takeda, and BMS; Speaker for Eli Lilly and Company. G. S. Kochhar: Advisory board for Eli Lilly and Company, GIE Medical, CorVetas Research Foundation, and Phramacosmos; consultant for Olympus Endoscopy, Boston Scientific Endoscopy, and Pentax Endoscopy; speaker for Eli Lilly and Company; stock options from DigBi Health. X. Liu, Consultant for Bristol Myers Squibb. U. Mahadevan: Consultant Abbvie, Bristol Myers Squibb, Boeringher Ingelheim, Celltrion, Enveda, Gilead, Janssen, Lilly, Merck, Pfizer, Protagonist, Rani Therapeutics, Roivant, and Takeda. U. Navaneethan: Consultant and advisory board for Abbvie, Janssen, Takeda, Pfizer, BMS, Lilly, and GIE Medical; speaker for Abbvie, Janssen, Pfizer, BMS, Lilly, Celltrion, and Takeda. M. Regueiro: Advisory board and consultant for Abbvie, Janssen, UCB, Takeda, Pfizer, BMS, Organon, Amgen, Genentech, Gilead, Salix, Prometheus, Lilly, Celgene, Boehringer Ingelheim Pharmaceuticals Inc (BIPI), and Celltrion. P. Sharma: Consultant for Olympus Corporation, Boston Scientific, Salix Pharmaceuticals, Cipla, Medtronic, Takeda, Samsung Bioepis, and CDx; research support from Erbe and Fujifilm. G. R. Lichtenstein: Consultant for Abbvie, American Regent, Bristol Meyers Squibb, Eli Lilly, Kabi Fresenius, MedEd Consultants, Janssen Orthobiotech, Pfizer Pharmaceuticals, Takeda, and UCB; research support from Bristol Meyers Squibb CME, Takeda, and UCB Consultant; continuing medical education sponsored by American Gastroenterological Association, American Regent (Creative Educational Concepts), Focus Medical Communication, AbbVie, Janssen, Ferring, Pfizer, Sanofi, Salix, Takeda, Bristol Meyers Squibb, Exact Sciences, Eli Lilly, Seres Pharmaceuticals, Boehringer Ingelheim, Pennsylvania Society of Gastroenterology; Data Safety Monitoring Board for Eli Lilly; royalties from UpToDate. All other authors disclosed no financial relationships., (Copyright © 2024 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.)